资讯

A new druggable cancer target: RNA-binding proteins on the cell surface
In 2021, research led by Ryan Flynn, MD, Ph.D., and his mentor, Nobel laureate Carolyn Bertozzi, Ph.D., opened a new chapter ...
Mena FN3 天
Cell Surface Markers Market Anticipated To Surpass US$68.147 Billion By 2030 At A CAGR Of 8.05%
The cell surface markers market is anticipated to grow at a CAGR of 8.05% from US$46.263 billion in 2025 to US$68.147 billion by 2030. The cell surface markers market is anticipated to grow at a ...
GEN3 天
Novel Leukemia Target Found in RNA-Binding Cell Surface Protein
as a potent selective target for treating acute myeloid leukemia (AML) as well as solid tumors. “Finding cell-surface targets that are specific to malignancies but spared on healthy tissue ...
EurekAlert!3 天
A new druggable cancer target: RNA-binding proteins on the cell surface
normal blood stem cells have almost no NPM1 on their surface.” Because it’s a surface marker, NPM1 is easily detectable with simple methods, and could provide a way to monitor patients.
Cancer Research12 天
Selective STING Activation in Intratumoral Myeloid Cells via CCR2-Directed Antibody–Drug ...
1Oncology Drug Discovery Unit, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts. *Corresponding Author: Adnan O. Abu-Yousif, Oncology Drug ...